![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Siegfried Evionnaz Sa Evionnaz Ch, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Oxybutynin hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2000-108 - Rev 04
This Chemical Type CEP, issued on December 10, 2015, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1354 associated with this CEP further emphasizes